ACAD
ACADIA Pharmaceuticals Inc
$20.28
0.46 (2.22%) Today
0.05 (0.27%) After-hours
— up— down
Market Cap
$3.48B-5.2%
Revenue (TTM)
$1.13B+47.0%
Net Income (TTM)
$378.87M+96.5%
EPS (TTM)
2.21+96.5%
Shares Out
171.24M
171.24MP/E Ratio
9.14
9.14Forward P/E
31.65
31.65Open
$20.22
$20.22Previous Close
$20.68
$20.68Day Range
$20.06 – $20.44
$20.06 – $20.4452-Week Range
$19.69 – $30.96
$19.69 – $30.96Beta
0.88
0.88Volume
2.51M
2.51MAvg Volume
1.68M
1.68MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout ACAD
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, California.
Related
News
N/AN/AN/AN/AN/A
Acadia's Daybue Patent Allowance Extends U.S. Protection to March 2041
Yahoo · 12h ago
Acadia Pharmaceuticals Announces Allowance of U.S. Patent Covering Weight-Banded Dosing of Trofinetide, extending U.S. patent protections to March 2041
Yahoo · 1d ago
Acadia Pharmaceuticals Announces USPTO Issued Notice Of Allowance For U.S. Patent Application No. 17/590,496, Titled “Methods and Compositions for Treatment of Rett Syndrome.”
Benzinga · 1d ago
3 Stocks Put Traders Are Targeting Today: AMTX, ACAD, REZI
Yahoo · 1d ago
Acadia Pharmaceuticals (ACAD) Stock Trades At A Discount After A 29% Drop
Yahoo · 2d ago